Increase of Ki‐67 index and influence on mortality in patients with neuroendocrine neoplasms-Reference-Cited by-同舟云学术

Increase of Ki‐67 index and influence on mortality in patients with neuroendocrine neoplasms

Published:2021-08-19 Issue:9 Volume:33 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinol

Author:

Holmager Pernille¹²^ORCID,Langer Seppo W.¹³⁴,Federspiel Birgitte¹⁵,Willemoe Gro Linno¹⁵,Garbyal Rajendra Singh¹⁵,Melchior Linea¹⁵,Klose Marianne¹²,Kjaer Andreas¹⁶,Hansen Carsten Palnaes¹⁷,Andreassen Mikkel¹²,Knigge Ulrich¹²⁷

Affiliation:

1. ENETS Neuroendocrine Tumor Centre of Excellence Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

2. Department of Endocrinology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

3. Department of Oncology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

4. Institute of Clinical Medicine University of Copenhagen Copenhagen Denmark

5. Department of Pathology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

6. Department of Clinical Physiology Nuclear Medicine & PET and Cluster for Molecular Imaging Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

7. Department of Surgery Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13018

Reference37 articles.

1. The 2019 WHO classification of tumours of the digestive system

2. Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET

3. Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors

4. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors

5. Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Intestinal, Colorectal, and Appendicular Neuroendocrine Tumors;Neuroendocrine Tumours;2024

2. High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent;Journal of Neuroendocrinology;2022-08-24

3. A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival;Frontiers in Endocrinology;2022-08-10

4. Imaging fluctuation of sulfite in mouse tumor and inflammation models with a novel quinoxaline-based fluorescent probe;Sensors and Actuators B: Chemical;2022-08

5. Volumetric parameters from [ ¹⁸ F ] FDG PET / CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms;Journal of Neuroendocrinology;2022-06-21